Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
Clinical trial NCT00078195 · COMPLETED
Trial details
- NCT number
- NCT00078195
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2005-05-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.